Trade Vir Biotechnology ^VIR

Vir Biotechnology poised for outperformance, keeps buy rating on pipeline potential By Investing.com

Needham & Company LLC Reaffirms Buy Rating for Vir Biotechnology (NASDAQ:VIR)

Empowered Funds LLC Decreases Stake in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program | Morningstar

Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program By Investing.com

Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta from European Medicines Agency By Investing.com

Vir Biotechnology stock hits 52-week low at $7.08 By Investing.com

Vir Biotechnology: Promising Hepatitis B Treatment Data Amid Cautious Optimism and Awaited Milestones

Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Sold by Baillie Gifford & Co.

Leerink Partnrs Expects Lower Earnings for Vir Biotechnology

Vir Biotechnology, Inc. (NASDAQ:VIR) EVP Verneuil Vanina De Sells 1,403 Shares

Barclays Cuts Vir Biotechnology (NASDAQ:VIR) Price Target to $26.00

FY2024 EPS Estimate for Vir Biotechnology Lowered by Analyst

Vir Biotechnology EVP vanina de Verneuil sells $32,332 in shares By Investing.com

Vanina Verneuil De - Insider Monkey

Vir Biotechnology Inc. (VIR) - Insider Monkey

VIR Biotechnology's SWOT analysis: stock poised for growth amid challenges By Investing.com

Vir Biotechnology (NASDAQ:VIR) Given New $26.00 Price Target at Barclays

HC Wainwright Reiterates "Buy" Rating for Vir Biotechnology (NASDAQ:VIR)

Blue Trust Inc. Has $30,000 Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology, Inc. (NASDAQ:VIR) Q3 2024 Earnings Call Transcript

Vir Biotechnology (NASDAQ:VIR) Announces Quarterly Earnings Results

Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ... By GuruFocus

Q3 2024 Vir Biotechnology Inc Earnings Call Transcript

Vir Biotechnology (NASDAQ:VIR) Shares Gap Down on Disappointing Earnings

Investors Purchase Large Volume of Call Options on Vir Biotechnology (NASDAQ:VIR)

Vir Biotechnology (NASDAQ:VIR) Earns "Buy" Rating from Needham & Company LLC

Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update | Morningstar

China Universal Asset Management Co. Ltd. Increases Stock Holdings in Vir Biotechnology, Inc. (NASDAQ:VIR)

Hennion & Walsh Asset Management Inc. Sells 3,690 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)

Vir Biotechnology (VIR) Scheduled to Post Earnings on Thursday

Vir Biotechnology (VIR) Set to Announce Quarterly Earnings on Thursday

Authority Investment Dhabi Abu - Insider Monkey